Table 2. BC-related characteristics of female patients.
| Characteristic | N = 3771 |
|---|---|
| Age at diagnosis | 48 (38, 59) |
| Age at menarchea | 14 (13, 15) |
| Age at menopausea | 45 (41, 50) |
| Age at first birtha | 20 (15, 25) |
| Paritya | |
| 1–3 | 146 (42%) |
| 4–7 | 134 (39%) |
| 8 and more | 64 (19%) |
| Family history of cancer | |
| No | 302 (80%) |
| Yes | 75 (20%) |
| BMIa | |
| Underweight | 30 (12%) |
| Healthy weight | 116 (45%) |
| Overweight | 75 (29%) |
| Obese | 35 (14%) |
| Stage | |
| I | 6 (1.6%) |
| II | 64 (17%) |
| III | 188 (50%) |
| IV | 119 (32%) |
| Gradea | |
| One | 29 (8.1%) |
| Two | 166 (46%) |
| Three | 164 (46%) |
| Her2 positivea | |
| No | 201 (75%) |
| Yes | 67 (25%) |
| Her2 negativea | |
| No | 72 (27%) |
| Yes | 196 (73%) |
| Triple-negative breast cancera | |
| No | 153 (57%) |
| Yes | 115 (43%) |
| Triple-positive breast cancera | |
| No | 117 (44%) |
| Yes | 151 (56%) |
| Surgery | |
| Modified radical mastectomy | 177 (47%) |
| Breast conservative surgery | 81 (21%) |
| Radiotherapy | |
| No | 232 (62%) |
| Yes | 145 (38%) |
| Chemotherapy | |
| No | 59 (16%) |
| Yes | 318 (84%) |
| Hormonal therapy | |
| No | 203 (54%) |
| Yes | 174 (46%) |
| Palliative treatment | |
| No | 228 (60%) |
| Yes | 149 (40%) |
| Missed the follow-up | |
| No | 374 (99%) |
| Yes | 3 (0.8%) |
1aPercentages may not sum to 100 because of missing data
Median (IQR); n (%)